Articles On Mach7 Technologies (ASX:M7T)

Title Source Codes Date
3 ASX penny stocks I don't think will be below 80 cents much longer

Small-cap shares suffered greatly during the period of 13 interest rate rises over 2022 and 2023. But with inflation cooling and the prospect of rate cuts coming, the little guys are starting to play catch up to the medium and large caps....

Motley Fool M7T 1 month ago
ScoPo’s (actually Wilkie’s) Powerplays: Health stocks rise as AdAlta soars 17% on trial results

ASX health sector rises in line with broader markets in the past five days  AdAlta reports positive Phase 1 extension trial results of AD-214 into IPF Mach7 signs $3.1 million, three-year renewal contract with Penn State Health Morgans h...

Stockhead M7T 1 month ago
Market Highlights: Records in sight for gold, Bitcoin; US chipmaker joins S&P500 and 5 small caps to watch

    Wall Street falls, Nvidia soars BTC nears all-time highs Gold to move even further?   The ASX is poised to start flat on Tuesday, after overnight losses on Wall Street. At 8am AEDT, the ASX 200 index futures contract was pointing up...

Stockhead M7T 1 month ago
Market Open: Flat start as Lucapa announces big diamond find

Futures predict the ASX200 will trade mostly flat this morning, maybe down just a touch on open. US markets were down a little ahead of the next round of economic data. The Nasdaq dropped 0.4 per cent, the Dow Jones shed a quarter of...

themarketonline.com.au M7T 1 month ago
ScoPo’s Powerplays: Health stocks fall as tight hospital budgets hurt Nanosonics

ASX health sector lifts in line with broader markets as reporting season comes to end Morgans upgrades Polynovo as total revenue rises 65.6% on pcp to $48.8 million  Nanosonics cites hospital budgetary pressures as deferring purchasing dec...

Stockhead M7T 1 month ago
FNArena Corporate Results Monitor – 01-03-2024

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((ALX)) - Atlas Arteria ((AFG)) - Australian Finance Group ((CAJ)) - Capitol Health ((CLU)) - Cluey ((DOC)) - Docto...

FNArena M7T 1 month ago
S&P/ASX 200 (INDEXASX:XJO) lower: ANZ Group Holdings Ltd (ASX:ANZ) down on miss!

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.40% to 6,948.80. A poor session to kick off the new trading week with the ASX snubbing the strength in...

Rask Media M7T 5 months ago
ScoPo’s Powerplays: Who fancies 22 minutes of exercise? And ASX health stocks are up (finally)

ASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports record quarterly sales orders for Q1 FY24 Aroa maintains FY24 revenue growth forecast at 30% after strong Q2 Healthcare and life sciences exp...

Stockhead M7T 5 months ago
Q A: Mach 7 CEO Mike Lampron on a barnstorming year and why AI isn’t the easy win it looks like

Mach7 Technologies reports third consecutive year of record sales growth in FY23 View on enterprise imaging extends beyond radiology CEO Mike Lampron says AI hurdles right now need to be overcome Morgans healthcare analyst Scott Power lik...

Stockhead M7T 5 months ago
MoneyTalks: Wilsons initiates coverage on Mach7 with lofty price target, Goldman rates Judo Cap a buy

Mach 7 Tech is rated Overweight by Wilsons, with price target of almost double Goldman slapped a Buy rating on neobank Judo Capital   Wilsons says Mach7 could be worth almost double current price Wilsons has initiated coverage of Mach7 Te...

Stockhead M7T 5 months ago
ScoPo’s Powerplays: ASX health stocks fall but Dimerix up 150% on drug licensing deal

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

Stockhead M7T 6 months ago
ScoPo’s Powerplays: ASX health stocks rise as big names ‘trading at very attractive fundamentals’

ASX health sector rises in line with broader markets as reporting season comes to end EBR Systems on schedule for key US FDA submission in Q1 CY24 for (WiSE) CRT system Health imaging company Mach7 achieves record sales order book of $40.3...

Stockhead M7T 7 months ago
FNArena Corporate Results Monitor – 01-09-2023

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIS)) - Aeris Resources ((AGI)) - Ainsworth Game Technology ((ALX)) - Atlas Arteria ((ATA)) - Atturra ((AUA)) - Audeara ((ASB)) - Austal ((BUB)) - Bubs Australia ((CCX))...

FNArena M7T 7 months ago
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging

Medical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI aims to grab market share Stockhead reached out to Curvebeam AI CEO, Greg Brown   Despite the recent rally, the ASX Healthcare Index (XHJ) is...

Stockhead M7T 7 months ago
ScoPo’s Powerplays: CSL leads ASX health stocks down is reporting season; ‘we weren’t expecting that’

ASX health sector falls in mixed week of FY23 results as reporting season continues Monash IVF reports solid FY23 result and forecasts higher IVF cycles going forward Ramsay healthcare plunges on disappointing FY23 result and cut in final...

Stockhead M7T 7 months ago
ScoPo’s Powerplays: Mesoblast sinks Health sector, and how to live 24 years longer

ASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes more than 50% after US FDA rejects a key product  ImpediMed falls after calls for board spill with discontent following cap raise Healthcare...

Stockhead M7T 8 months ago
Why this little ASX healthtech share is charging 7% to a 52-week high on Friday

The Mach7 Technologies Ltd (ASX: M7T) share price is having a strong finish to the week. In morning trade, the ASX health technology share is up 7% to a 52-week high of 97.5 cents. Why is this ASX share shooting higher? Investors have been...

Motley Fool M7T 8 months ago
Market Highlights: Earnings weigh on Wall Street; VIX falls below 14, signals ‘new bull market’

The ASX will open lower on Friday as earnings weighed on Wall Street The “fear gauge” CBOE index is at lowest since 2020 Bitcoin spot ETFs to significantly increase BTC demand, says analyst   Local shares are set to open lower on Friday a...

Stockhead M7T 8 months ago
ScoPo’s Powerplays: ASX health stocks fall in first week of FY23 as Mach 7 scores biggest deal in its history

ASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60 million Veterans contract – the most significant in its history Neuren completes recruitment for Phase II trial of NNZ-2591 in Phelan-McDer...

Stockhead M7T 9 months ago
ASX Health Stocks: Lumos soars 327pc after US FDA approval for aid to detect bacterial respiratory infections

Lumos soars after US FDA approval for FebriDx rapid, point-of-care test Emyria will buy the Pax Centre for $1.7 million following psychedelic medicine law changes in Australia Rhythm Biosciences establishes UK subsidiary as part of strateg...

Stockhead M7T 9 months ago
ScoPo’s (actually Wilkie’s) Powerplays: Inoviq soars on clinical data for breast cancer test

Clinical validation study confirms efficacy of INOVIQ’s SubB2M/CA15-3 test for breast cancer Ramsay releases several announcements this week including possible sale of joint Asian venture Mach 7 expects significant cash collections in Q4...

Stockhead M7T 9 months ago
ScoPo’s Powerplays: ASX health stocks rise, Immutep surges 46pc on trial results

ASX health stocks rise in the past five days in line with broader markets Immutep  surges 46% after positive Phase 2 results into lung cancer Avita Medical falls 28% in past five days despite reporting “solid Q1 FY23” results Healthcare a...

Stockhead M7T 10 months ago
ScoPo’s (he’s back) Powerplays: ASX health stocks fall, Volpara ‘elephants’ strategy pays off

ASX health stocks fall 0.8% in the past five days in line with broader markets following latest rate hike Investors rewarding health stocks with near term catalysts in 2023, including Neuren and Impedimed Health imaging stock Volpara recor...

Stockhead M7T 11 months ago
Mach 7 positions for enterprise imaging uptake solving tomorrow’s problems with today’s software

Mach7 primed for growth as move towards enterprise rather than departmental imaging grows Company’s three modular products are a unique fit for use case of enterprise imaging Mach7 landing big clients as it works to solve tomorrow’s probl...

Stockhead M7T 1 year ago
Why growth is a positive for the ASX medical imaging sector

The medical imaging market size globally is forecast to reach $68.8 Billion by 2030 Several ASX health imaging stocks are establishing strong footholds and niches in sector Micro-X branching out from the medical sphere with its bomb detect...

Stockhead M7T 1 year ago
Mach7 Technologies (ASX:M7T) begins final PACS deployment phase with Adventist Health

Mach7 (M7T) receives a $7.1 million order from Adventist Health for Mach7 picture archiving and communication systems (PACS) for another 15 hospitals This marks the final deployment phase of a 22-hospital contract signed in January 2021,...

themarketherald.com.au M7T 1 year ago
ScoPo’s Powerplays: ASX health stocks fall but keep watchful eye on upcoming catalysts

ASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a statutory loss of ~$29 million following reduced demand for Covid-19 testing Catalysts in next few months for several ASX health stocks which co...

Stockhead M7T 1 year ago
FNArena Corporate Results Monitor – 01-03-2023

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABC)) - Adbri ((AHL)) - Adrad ((AIS)) - Aeris Resources ((AMX)) - Aerometrex ((AOF)) - Australian Unity Office Fund ((AVG)) - Australian Vintage ((BBT)) - BlueBet Holdin...

FNArena M7T 1 year ago
Market Highlights: Dilbert comic dropped, ASX to rise, and 5 small caps to watch on Tuesday

The ASX is set to track Wall Street and move higher at the open The DoE says Covid-19 came from a ‘lab leak’ Coinbase to suspend trading of Binance USD   The ASX is set to open stronger on Tuesday after US stocks rose in New York. At 8am...

Stockhead M7T 1 year ago
ScoPo’s Powerplays: ASX health stocks have lacklustre week as Monash IVF continues to gain market share

ASX health stocks fall 1.2% in the past five days  as macro economic factors weigh on broader markets Monash IVF has reported a solid H1 FY23 result with underlying NPAT of $12.6m, ahead of guidance Pharmaceutical distribution group  EBOS...

Stockhead M7T 1 year ago
Broker says these small cap ASX shares offer big returns potential

If you have a high tolerance for risk, then you might want to consider adding some small cap exposure to your portfolio. But which small cap ASX shares should you buy? Listed below are two that Morgans rates very highly. Here’s why it is...

Motley Fool M7T 1 year ago
ScoPo’s Powerplays: ASX health stocks sprout 4.6%, as Volpara soars on first positive cash flow

ASX health stocks rise 4.6% this week with positive signs of being back in favour Volpara soars after announcing its first net cash flow positive quarter Morgans basket of healthcare stock picks for 2023 faring well,  all up YTD Healthca...

Stockhead M7T 1 year ago
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Stockhead M7T 1 year ago
ScoPo’s Powerplays: Volpara leads a minor ASX small cap health sector renaissance

ASX health stocks rise 0.8% this week as smaller names in sector show signs of being back in favour Volpara signs five 5-year contracts worth more than US$7.8 million in Total Contract Value Mach 7 continues its 2023 recovery after announc...

Stockhead M7T 1 year ago
ScoPo’s Powerplays: ASX health stocks fall as Mach7 lands its biggest customer yet

The ASX Health sector has fallen ~1.5% in its first trading week of 2023 Mach7  has surged after landing its largest ever customer contract Proteomics gets US approval for PromarkerD test for diabetic kidney disease Healthcare and life sc...

Stockhead M7T 1 year ago
Top ASX shares to buy in January 2023

It’s certainly been a rollercoaster for ASX investors in 2022. But now, it’s time to disembark and begin a whole new ride! Will rising inflation and recession fears derail the carriage again in 2023? Or will China fully reopen and central...

Motley Fool M7T 1 year ago
CLOSING BELL: Legless Aussie markets set fresh record for running out of steam

2023 off to a bit of a dismal start, down 1.3% on the opening day of trade GreenX soaring after rumblings from Poland over $1.3 billion payday Chinese markets gain before the rest of the trading world gets back from holidays   For about 1...

Stockhead M7T 1 year ago
Mach7 (ASX:M7T) signs largest-ever customer contract, shares soar 20%

Highlights Mach7 entered a customer contract with Akumin Inc. The company expects to recognise revenue of AU$7.5 million in FY23 through this largest-ever customer contract. The contract has been signed under a 10-year term with a tot...

Kalkine Media M7T 1 year ago
Mach7 (ASX:M7T) share price soars on large new contract

The Mach7 Technologies Ltd (ASX: M7T) share price has jumped after the company announced a multi-year contract worth $16.7 million. This business is a medical imaging systems provider that develops image management and viewing solutions for...

Rask Media M7T 1 year ago
ASX Health Stocks: Mach7 lands biggest customer in history, share prices surges 20pc

Mach7 signs up biggest client in its history Proteomics gets major regulatory approval in the US   ASX medical imaging specialist Mach7 Tech (ASX:M7T) surged 20%  to ~4 month highs on the first trading day of 2023 after landing the larges...

Stockhead M7T 1 year ago
Mach7 Technologies kicks off new year with $16.7m enterprise imaging platform order

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Medical imaging software solutions provider Mach7 Technologies (ASX: M7T) has kicked off the new year with a $16.7 million order for its enterprise imaging platform fr...

SmallCaps M7T 1 year ago
Mach7 signs $17 million contract – share price jumps 20% at open

The Mach7 Technologies Ltd (ASX: M7T) share price is off to the races on this first day of trading in 2023. Shares in the ASX listed medical imaging systems provider leapt more than 20% on open and are currently up 18.4% in morning trade....

Motley Fool M7T 1 year ago
Market Highlights: ASX to kick of 2023 on a high note, and 5 small caps to watch on Tuesday

The ASX is poised to open higher on the first day of 2023 Wall Street had one of its worst years in 2022 IMF warns of a tougher year   Aussie shares are set to advance on the first trading day of the year. At 8am AEDT, the ASX 200 Jan fut...

Stockhead M7T 1 year ago
Mach7 Technologies (ASX:M7T) signs multi-year $16.7m contract

Mach7 Technologies (M7T) signs a ten-year deal with Akumin to consolidate its system into a common enterprise solution for $16.7 million The agreement involves the company’s entire enterprise imaging platform to provide a true cloud-base...

themarketherald.com.au M7T 1 year ago
Why AGL, Invictus Energy, Maas, and Mach7 shares are pushing higher today

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and dropped into the red. At the time of writing, the benchmark index is down 0.55% to 7,094.7 points. Four ASX shares that are not letting that ho...

Motley Fool M7T 1 year ago
Dr Boreham’s Crucible: Mach7 Technologies

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player By Tim Boreham Observers of the medical imaging space - your columnist included - have delighted in highlighting the yawning gap be...

FNArena M7T 1 year ago
ScoPo’s Powerplays: Calmer week for ASX health stocks with some alarming stats about how many people drink instant coffee

During latest period of volatility many health stocks have seen their share prices remain quite stable Several ASX health stocks have rallied this week on positive news including Polynovo on $5 million sales month Telix Pharmaceuticals ral...

Stockhead M7T 1 year ago
Rudi’s View: Bega Cheese, Computershare, NextDC, Playside Studios, Treasury Wine And Qantas

In this week's Weekly Insights:-Inflation & House Prices-Conviction Calls-Research To DownloadBy Rudi Filapek-Vandyck, Editor Inflation & House PricesOne of the more eye-catching forecasts made recently is that persistent inflation...

FNArena M7T 1 year ago
Broker names 2 small cap ASX shares to buy now

Wanting some ASX small caps in your portfolio? If you are, check out the two listed below that Morgans rates as buys. Here’s what the broker is saying about these small caps: Acrow Formwork and Construction Services Ltd (ASX: ACF) The...

Motley Fool M7T 1 year ago
Webinar Recap – XPN, M7T, SHP & NMT

ShareCafeWebinar Recap – XPN, M7T, SHP & NMT Catch up on the full webinar presentations from Xpon Technologies (ASX: XPN), Mach7 Technologies (ASX: M7T), South Harz Potash (ASX: SHP) & Neometals (ASX: NMT) Webinar Recap – XPN, M7T,...

ShareCafe M7T 1 year ago